Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0175)

Milan, Lombardy 20133

3 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Malignant Neoplasm, Non-small Cell Lung Cancer

Studies at this site

• KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J) — Recruiting now
• A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01) — Recruiting now
• A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01) — Recruiting now